The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies

BACKGROUND: CYP2E1 encodes a member of the cytochrome P450 superfamily of enzymes which play a central role in activating and detoxifying many carcinogens and endogenous compounds thought to be involved in the development of cancer. The PstI/RsaI and DraI polymorphism are two of the most commonly st...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Kefu, Li, Yang, Zhang, Zhao, Gu, Yunmin, Xiong, Yuyu, Feng, Guoyin, He, Lin, Qin, Shengying
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988025/
https://www.ncbi.nlm.nih.gov/pubmed/20969746
http://dx.doi.org/10.1186/1471-2407-10-575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988025/
https://www.ncbi.nlm.nih.gov/pubmed/20969746
http://dx.doi.org/10.1186/1471-2407-10-575

Ejemplares similares